Ibogaine in Puerto Rico: Science, Safety, and the First Step Toward Responsible Research
14 min read
Today, August 4, 2026, Governor Jenniffer A. González Colón signed Executive Order OE-2026-037, which establishes Puerto Rico's public policy directed at strengthening clinical research, the development of controlled clinical trials, and the scientific capacity of the island's health system in emerging therapies, a category that includes, among others, psychedelic therapies and ibogaine compounds.








